Tel: (904) 562-4400. Oliver Sartor, MD. The FDA has approved piflufolastat F 18 (Pylarify) injection, a prostate-specific membrane antigen (PSMA)–targeted positron emission tomography (PET) imaging agent, to identify suspected. 11/30. NCCN Category 2A designation supports coverage of IGH and TP53 gene testing for Chronic Lymphocytic Leukemia (CLL) patients. PYLARIFY is the first and only commercially available, FDA-approved PSMA-targeted PET imaging agent for prostate cancer NORTH BILLERICA, Mass. Most PET scans use a type of sugar as a tracer. [1] [4] [5] It is given by intravenous injection. The PET scan is like a high-tech 'camera' that turns a small amount of radiation into pictures. by year endNORTH BILLERICA, Mass. This includes patches. HCP administered. Get prescription saving tips and more from GoodRx Health. • For lactate dehydrogenase (LDH) levels greater than 2 × the upper limit of normal (ULN), adjust the dosing regimen to 1,080 mg every three days. 9% Sodium Chloride Injection, USP. with. THOUSAND OAKS, Calif. PYLARIFY may be diluted with 0. SoFi members with Direct Deposit or $5,000 or more in Qualifying Deposits during the 30-Day Evaluation Period can earn 4. Preparation and Administration. There are going to be a couple of other agents coming to the market. Medical technology is continuously evolving; our coverage policies are subject to change without prior notice. Choose from a fruity citrus or floral rose or lavender, the spice of cinnamon or woodsy sandalwood. PYLARIFY® CODING AND BILLING GUIDE | PYLARIFY® Reimbursement Hotline: 844-339-8514 PYLARIFY® and the associated services provided in a physician office are billed on the CMS-1500 claim form or its electronic equivalent. In. Through rigorous analytical and clinical studies, PYLARIFY AI has demonstrated improved consistency, accuracy and efficiency in quantitative assessment of PSMA PET/CT. S. If your doctor wants to prescribe a drug that is not. 8 million, compared to a loss of $21. Pediatric Acute Lymphoblastic Leukemia Version 3. I’m 58 With $700k in Retirement Savings, But I Won’t Collect Social Security for 7 Years appeared first on SmartReads by SmartAsset. PYLARIFY, approved by the FDA in May 2021, is the first commercially and widely available prostate-specific membrane antigen (PSMA) PET imaging agent. Life-saving advancements from companies like Lantheus Holdings (NASDAQ:. Reno, Nevada (UroToday. Thirty-one out of thirty-four molecules contain at least one heterocyclic ring, and eleven out of thirty-four molecules contain at least one fluorine atom. 9 mg ethanol in 0. This means that a negative PYLARIFY PET/CT scan does not rule out that you have prostate cancer, and a positive PYLARIFY PET/CT scan does not confirm that you have prostate cancer. de. 51% for 90 days. U. Member FDIC. Medicare did not pay for the Pylarify used in PSMA PET/CT Scan. PYLARIFY PET/CT scan could interpret your results incorrectly. Compare prices and print coupons for Pylarify (Piflufolastat F 18) and other drugs at CVS, Walgreens, and other pharmacies. Password. Have a My HealtheVet Premium * account. Pylarify may also be used for purposes not listed in this medication guide. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider. Pylarify; Descriptions. You cannot fill this prescription in a regular pharmacy. Online checking accounts. Pylarify = 18F-DCFPyL, mentioned above. Lantheus Holdings, Inc. Phone: 1-800-964-0446. Injection. The June 2021 release of Pylarify set in motion a new series of price increases. NORTH BILLERICA, Mass. GoodRx coupons are not available at HCP offices for these medications, but there might be other ways you can save on your. An FDA-cleared medical. Money market accounts. PYLARIFY ® (piflufolastat F 18) Injection In the U. 9% Sodium Chloride Injection, USP. , [18 F]-DCFPyL was approved by the Food and Drug Administration (FDA) in May 2021 and is commercially available as PYLARIFY ® (Piflufolastat F 18 Injection) and sold by Lantheus. 6 - Positron Emission Tomography (PET) Scans (RETIRED) (Rev. 10. Use aseptic technique and radiation shielding when preparing and administering. The doctors can know about the survival chances of the patient as well. Make sure they know all the medications you’re taking. An amide is an organic functional group with a carbonyl bonded to a nitrogen or any compound containing this functional group. Under the approval, the tracer can be used in PET imaging for prostate cancer that is suspected of having spread to other parts of the. For example, shares gapped up 11% in November of last year following the company's quarterly report. The patient’s last meal prior to the PET study (which is typically the day before the study) should have a high protein and low carbohydrate content. PYLARIFY® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. ” Although this is a radioactive compound, it is well-tolerated, he adds. Personalize QR Codes and promote your products and services on your socials or in person. DULLES, Va. 8 - other international versions of ICD-10 J94. and $50,000 in a high-yield savings account. PYLARIFY® (Piflufolastat F 18 Injection) and sold by Lantheus. Two kinds of PSMA PET indicators are FDA-approved for recurrent patients and high-risk patients: Pylarify and Ga68PSMA11. (NASDAQ:LNTH) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good morning. FDA clearance letter for aPROMISE X. It is most commonly used for evaluating primary and metastatic well-differentiated neuroendocrine tumors. (the “Company”) (NASDAQ: LNTH), an established leader and fully. Gross anatomy. 9h ago. Read more. To qualify for Pluvicto, one needs a positive PSMA PET scan, but. This means that a negative PYLARIFY PET/CT scan does not rule out that you have prostate cancer, and a positive PYLARIFY PET/CT scan does not confirm that you have prostate cancer. 9% Sodium Chloride . For patients in the new Atlanta patient tower: call 404-780- [patient's room number]. Online checking accounts. Select appropriate option from main menu to use the IVR or speak with a Customer Service Representative. The recommended amount of radioactivity to be administered for PET imaging is 333 MBq (9 mCi) with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi) administered as a single bolus intravenous injection. The approved prescription drugs that Horizon NJ Health covers make up our formulary. This Web application will allow you to calculate the activity of a radionuclide after a specified interval of time. This drug is administered by your healthcare practitioner (HCP), which usually means: It may be expensive. You’ll see how much the patient pays with Original Medicare and no supplement (Medigap) policy. Contact phone numbers will no longer default in on orders. with suspected recurrence based on elevated serum levels of prostate-specific antigen (PSA) level. Same pills. The pH of the solution is 4. PET-CT scans are a useful tool in: Choosing the best treatment. The company only. PYLARIFY is a sterile, non-pyrogenic, clear, colorless solution for intravenous injection. Periodic health exams, cancer screenings, vaccines and other recommended preventive care services help prevent or detect problems early on when they’re easier to treat. Use in men who might have prostate cancer. 00. com on Trademark Filing, Trademark Renewal, Office Action, and Notice. The doctor’s office will process any payments related to your visit and treatment. The NDC Code 71258-022-00 is assigned to “Pylarify ” (also known as: “Piflufolastat F-18”), a human prescription drug labeled by “Progenics Pharmaceuticals, Inc. ILLUCCIX, after radiolabeling with GA 68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: With suspected metastasis who are candidates for initial definitive therapy. Revenue. Our surgeons are also highly experienced in a procedure called salvage radical prostatectomy. 9 mg ethanol in 0. 1 million for the third quarter 2021, representing an increase of 15. Pylarify received priority review designation for this approval. A. The incidence of prostate cancer increases with patient age, with an incidence rate of 1 in 350 men for those under 50 years of age, climbing to an incidence of 60% in men over the age of 65. In addition to clinical drug information, FDB publishes several drug pricing data fields, including: FDB discontinued the publication of Blue Book Average Wholesale Price (AWP) on September. Email: cspyl@lantheus. Some of these are renally cleared; some of these are hepatically cleared. Please note the Amyvid production days have been updated to accommodate commercial Tauvid production. Application error: a client-side exception has occurred (see the browser console for more information). 29, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. CPT Code 78815. • Dispose of any unused PYLARIFY in compliance with applicable regulations. Tell your doctor if you or your child. Enter your email to sign up. Welcome to the Lantheus Third Quarter 2023 Financial Results. In addition to the commercial upside, PYLARIFY's approval bolsters the company's radiopharmaceutical portfolio that could turn Lantheus into a formidable presence in this arena. The Gleason score is used to determine the Grade Group. Do not eat for 18 hours. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia. With suspected recurrence based on elevated serum. Español. PYLARIFY ® (piflufolastat F 18) injection (also known as 18 F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and. You cannot fill this prescription in a regular pharmacy. 9% Sodium Chloride Injection USP. This is accomplished by development and execution of a territory business strategy to educate the Prostate Cancer (PCa) treating (and referring). 0. Show coupon to your pharmacist Present your printed or electronic coupon when you pick up your prescription. Each milliliter contains 37 to 2,960 MBq (1 to 80 mCi) piflufolastat F 18 with ≤0. MyUHealthChart also provides convenient methods of communication with your doctor’s office. • Dispose of any unused PYLARIFY in compliance with applicable regulations. 264. This drug is likely to be covered under your medical benefit if you have insurance. 01 µg/mCi of piflufolastat at calibration time and date, and ≤ 78. The ability to combine functional and anatomical information has equipped PET/CT to look into various aspects of lung cancer, allowing more precise disease staging and providing useful data during the. 9 mg ethanol in 0. 7 mi. Inject a bolus of 9 mCi (333 MBq) of PYLARIFY® with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi) administered as a single bolus intravenous injection. Worldwide revenue of $102. It seems that the approved Medicare payment will be $ 5,224. It ensures that high-quality health services are accessible, and works to reduce health risks. 73 m 2 BSA ( chronic kidney disease Chronic Kidney Disease Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. The idea with PET scan is that cancerous tissues will be more. PYLARIFY AI offers a standardized platform for physicians and researchers to efficiently, consistently and accurately quantify PSMA uptake at the lesion level for men with prostate cancer. The safety of PYLARIFY was evaluated in 593 patients pooled from the two trials, each receiving a single dose of PYLARIFY. Nano-X reported $2. Our. S. 1 Standardized PSMA PET reporting provides consistent and precise disease. Only use the credentials given to you by your clinic. Ingredients. Illuccix is a healthcare provider (HCP) administered medication. PYLARIFY is a sterile, non-pyrogenic, clear, colorless solution for intravenous injection. 00 thru 2/28/21. with suspected recurrence based on elevated serum levels of prostate-specific antigen (PSA) level. 05. After injection, imaging of positron emitters such as gallium-68 ( 68. Each milliliter contains 37 to 2,960 MBq (1 to 80 mCi) piflufolastat F 18 with ≤0. 1. Login. Piflufolastat F-18, sold under the brand name Pylarify among others, is a radioactive diagnostic agent used for positron emission tomography (PET) imaging. 0. • Assay the dose in a suitable dose calibrator prior to administration. Kerendia. 0. /5. 5 million Medicare Advantage members. Lower prices. It is carried out by injection of a radiopharmaceutical with a positron or gamma emitting radionuclide and a prostate-specific membrane antigen (PSMA) targeting ligand. There are several types of PET Scans, and it is important that you follow the preparations your scan. , a Lantheus company, for positron emission tomography (PET) that targets prostate-specific membrane antigen (PSMA). December 01, 2020. 0 million and $150. • Dispose of any unused PYLARIFY in compliance with applicable regulations. Providers must read the entire NCD and related Internet Only Manual (IOM) sections (see "Sources" at end of this article) in order to correctly understand and apply the following coding guidance. PYLARIFY is a sterile, non-pyrogenic, clear, colorless solution for intravenous injection. Gallium-68 DOTATATE (or Ga-68 DOTATATE) is a PET radiotracer that is a form of somatostatin-receptor (SSTR) functional imaging. Your doctor, hospital, or clinic will provide this medication. 9% sodium chloride injection USP. Under this FDA approval, patients must have a positive scan with an approved gallium-68-PSMA-11 agent to be selected for treatment with Lu-PSMA. The radiation harms and kills cancer cells. 5. It is very specific to the prostate as very few organs exhibit PSMA. Santa Monica Breast Center. November 29, 2021 at 8:30 AM EST. Discuss your imaging options with your Referring Physician, or feel free to call us here at ADR if you have any questions about our services. HCP administered medications are sold and given to you by your physician. The Membership Join/Renew form is undergoing maintenance. It targets the extracellular PSMA component to visualize prostate cancer cells anywhere in the body. , A Siemens Healthineers Company, supports the growth of our customers' business with on-time delivery of PET tracers and comprehensive value-added services. PYLARIFY® may help detect metastases even when PSA levels are low. Subscribe. As a leader in the development, manufacture and commercialization of pioneering diagnostic and therapeutic products, we’re determined to Find, Fight and Follow ® a broad range of diseases. com. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. FDA Approves 18F-DCFPyL PET Agent in Prostate Cancer T heU. INDICATION. 0. The higher face value. Koontz: Pylarify is an F 18-DCFPyL, which is a PSMA PET. The Women’s Hospital | Jackson Memorial. I’m 58 With $700k in Retirement Savings, But I Won’t Collect Social Security for 7 Years appeared first on SmartReads by SmartAsset. Lantheus expects their fully diluted adjusted earnings per share to be between $0. I have a $220,000 mortgage. 220. By targeting PSMA, PYLARIFY® can give your doctor a clear image and additional information on the location and extent of the cancer. 3 million in the first quarter of 2023, representing an increase of approximately $92. We are able to offer our patients a full spectrum of state of the art imaging capabilities. Even better: Combine it with other deals in order to max out your savings. as low as. Pylarify (piflufolastat F 18) Rubidium chloride rb-82. Your doctor, hospital, or clinic will provide this medication. -1. November 29, 2021 08:30 ET | Source: Lantheus Holdings, Inc. For men with prostate cancer, PYLARIFY PET. For UCSF patients , please reach out to Radiology Scheduling (415) 353-3900 directly to schedule your PSMA scan. We are confident that you will find our pricing offers savings comparable to our local competition and area hospitals. Prostate cancer is the most common non-dermatologic cancer in men, and the second leading cause of cancer-related death. It is because the cancer cells have a higher metabolic rate and appear as large dark-colored spots in the PET scan report. Easy mobile app download in your phone’s app store. In some cases, depending on the clinical scenario, the same diagnosis code describes a. N/A. Claims reviewed for cardiac blood pool imaging/gated Equilibrium studies (78472, 78473, 78494, and 78496) were submitted with incorrect radiopharmaceutical codes. Pylarify PET detected at least one positive lesion in at least one body region (bone, prostate bed, pelvic lymph node, other lymph nodes, or soft tissue) in 60% of these patients. This drug is likely to be covered under your medical benefit if you have insurance. Cancer of the ureter (ureteral cancer) is an abnormal growth of cells on the inside lining of the tubes (ureters) that connect your kidneys to your bladder. We are here to help! CWS SHP 001 NF 082018. Our Approach Services Breast Program Support Services and Education. Find your nearest center to order PYLARIFY® for PET/CT scans, as well as downloadable resources and reimbursement support inf. In the U. PYLARIFY uptake is not specific for prostate cancer and may occur with other types of cancer as well as non-malignant processes and in normal tissues. Send Email to Patient Portal Support. *To get a My HealtheVet. (NYSE: HUM) announced additional actions to help protect, inform and care for its nearly 4. PYLARIFY AI™ (aPROMISE). 18 F-FDG (a glucose analog) is taken up by cells via glucose transporter proteins. High-yield savings accounts. , May 28, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U. This study aimed to. Chest to Head Neck $3,000 – $10,700. Saving $1 million (or more) for retirement is a great goal to have. Covered Drugs. The Johns. S. Indications and Limitations of Coverage. Indication. PYLARIFY ® (piflufolastat F 18) Injection . Side effects of Pylarify include: headache, changes in taste, and. Oliver Sartor, MD. PYLARIFY® is an imaging agent for PET/CT scans that uses a unique combination of a PSMA-targeted small molecule and the radioactive tracer 18 F to help your doctor make more informed treatment choices based on clear images. Compare Prices Specify your dosage and quantity to find out exactly how much you can save. PYLARIFY is a sterile, non-pyrogenic, clear, colorless solution for intravenous injection. PYLARIFY AI™ Indications for Use PYLARIFY AI is intended to be used by healthcare professionals and researchers for acceptance, transfer, storage, image display, manipulation, quantification and reporting of digital medical images. PyL PET imaging is approved for two types of patients with. 72 at the end of last week, then rose to as high. PYLARIFY® (piflufolastat F 18) injection is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis. “I feel proud to be a part of the Lantheus team. PSMA or Pylarify PET-CT scan that confirms you have PSMA-positive prostate cancer. 3 . HCP administered medications are sold and given to you by your physician. LoginDOI: 10. We follow recommendations from. Call 305-243-5512 Request an Appointment. This trademark was filed to the Canadian Intellectual Property Office on Monday, April 6, 2020. PETNET Solutions Inc. 1. The approval covers the use of Lu177-PSMA-617 in patients who have metastatic prostate cancer that is hormone-resistant (also known as castrate-resistant) and whose tumors. 5 miles away. PYLARIFY® PET/CT combines the accuracy of PET imaging, the precision of PSMA targeting, and the clarity of an. PYLARIFY® attaches to prostate-specific membrane antigen (PSMA), a protein found on the surface of most—approximately 95%—prostate cancer cells. As you may know, the FDA only approved 68Ga-PSMA-11 PET to qualify for Pluvicto. 7 million in the same period last year. PYLARIFY ® (piflufolastat F 18) injection (also known as 18 F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and. Non-equivalent Resonance Structures. 12. That's because. Make sure they know all the medications you’re taking. Reference is also made to your clinical pharmacology response of November 19, statistical response of December 23, clinical response of December 29, 2020, statistical response of The NCCN has added Ga 68– and F 18–based PSMA-PET imaging modalities to its clinical practice guidelines for prostate cancer. S. Purpose. Coverage is provided for IGH and TP53 genes to facilitate decision-making in the medical management of Chronic Lymphocytic Leukemia (CLL) patients. Insight Blog. The doctor’s office will process any payments related to your visit and treatment. This drug is administered by your healthcare practitioner (HCP), which usually means: It may be expensive. Food and Drug Administration. 69. Lantheus Holdings. , North Billerica MA 01862,UNITED STATES. Here you will find links to several key resources for health care professionals to help your practice perform efficiently and make it easier to do business with Cigna. Policies, Guidelines & Manuals. The short answer is that a PET scan helps in the workup of an abnormality in the lung, but can not definitely rule in or rule out a cancer. 5 to 7. News & World Report. This drug is likely to be covered under your medical benefit if you have insurance. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. 11/11/2022. Additionally, some health plans administered by Cigna Healthcare. CT scan. Cancer is in two lymph nodes near to one another and on the same side of the body, or the cancer is in one organ and nearby lymph. The facility billed about $10,000+ , half for the PET/CT, and half for the Pylarify. The Department of Health Policy and Management, one of the largest in the country, is dedicated to advancing local, national, and global health policy to make a difference. I have government insurance If you have Medicare/Medicare Part D, Medicaid, or another government insurance plan, Pfizer Oncology Together can help identify financial support. Additional coverage policies may be developed as needed or may be withdrawn from use. GFR* 15 mL/min/1. Little Miracles Maternity Suites. Pylarify; Descriptions. Revenue. Article Text. Piflufolastat F 18 injection is used with a PET scan (positron emission tomography) of prostate-specific membrane antigen (PSMA) positive lesions in men with. 01. Providers must read the entire NCD and related Internet Only Manual (IOM) sections (see "Sources" at end of this article) in order to correctly understand and apply the following coding guidance. Medicare billing and coding guidelines on telehealth for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs). Purpose: The prostate-specific membrane antigen (PSMA) targeted positron-emitting-tomography (PET) tracer 68 Ga-PSMA-11 shows great promise in the detection of prostate cancer. PYLARIFY® is an imaging agent for PET/CT scans that uses a unique combination of a PSMA-targeted small molecule and the radioactive tracer 18 F to help your doctor make more informed treatment choices based on clear images. 50. To view your VA Radiology reports you must: Be a Veteran enrolled at a VA health care facility. In the United States, the average wholesale price (AWP) is a pharmaceutical term that describes the average price paid by a retailer to buy a drug from the wholesaler. Specialty Care. Post Administration Instructions • Follow the PYLARIFY injection with an intravenous flush of 0. PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. Log on to any computer, from anywhere, any time of day to stay on top of your health information such as results, appointment summaries, medications, and immunizations. More Info See Prices. The June 2021 release of Pylarify set in motion a new series of price increases. In 2020, the FDA approved 53 new molecular entities, including 34 small molecules and 4 diagnostic agents [ 49 ]. 5 to 7. Date Published (original date) 2021. 5 mL to 12. Each milliliter contains 37 to 2,960 MBq (1 to 80 mCi) piflufolastat F 18 with ≤0. Locations. Search or Select from Dropdown. 4. 45%. PYLARIFY® FOR PCa IMAGING; EFFICACY AND SAFETY. 29, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. 2161 Kingsley Ave, Ste 100. This scan is used to diagnose cancer in the prostate gland. If approved for Europe, PYLCLARI ® (INN: Piflufolastat (18 F) formerly known as [18 F]-DCFPyL) will offer prostate cancer patients access to a diagnostic imaging agent more sensitive than conventional imaging. Two huge advances have dramatically changed the diagnosis and treatment of metastatic prostate cancer, and both of these involve prostate-specific membrane antigen (PSMA), a molecule that sits on the surface of prostate cancer cells. Generic drugs are generally cheaper than brand-name drugs, but you can still find Pylarify savings through NiceRx. I earn $300,000 per year and put $30,000 in my 401(k) each year plus a match on the first 6%. Radiation therapy (radiotherapy) uses high-energy beams to treat cancer. There’s obviously Pylarify [piflufolastat]. It is both sensitive and specific in detecting liver metastases from a wide range of primary cancers, and may change clinical management, most commonly by detecting. Active ingredient: relugolix Inactive ingredients: mannitol, sodium starch glycolate, hydroxypropyl cellulose, magnesium stearate, hypromellose, titanium dioxide, ferric oxide red, and carnauba wax. Pluvicto is a targeted radioactive therapy. You can get. 1 year ago • 15 Replies. 1. 00 anymore and it is billing Medicare and secondary insurances for part B. Tauvid. The simplest amides are derivatives of ammonia. VA Radiology is part of the My HealtheVet Personal Health Record found under the VA Blue Button section. PYLARIFY AI™ (aPROMISE). PYLARIFY ® (piflufolastat F 18) Injection . 12/05. Xofigo. IGH and TP53. , Nov. Nuclear medicine uses small amounts of radioactive material called radiotracers. Assay the dose in a suitable dose calibrator prior to administration. Radiology/Imaging Services. J94. Through rigorous analytical and clinical studies, PYLARIFY AI has demonstrated improved consistency, accuracy and efficiency in quantitative assessment of PSMA PET/CT. PYLARIFY Injection is designed to detect prostate-specific membrane. All Drugs; Human Drugs; Animal Drugs. The platform. Online Ordering System.